Showing posts with label microbiota. Show all posts
Showing posts with label microbiota. Show all posts

Thursday, 15 January 2026

Revealing The Gut-brain Connection: The Effects of Microbiota Extend Beyond Digestion | Chapter 9 | Pharmaceutical Science: New Insights and Developments Vol. 9

 

The gut microbiome is a dynamic internal ecosystem that plays a crucial role in shaping our overall health. A balanced gut microbiome aids in digestion, nutrient absorption, immune function, mental clarity, and emotional regulation, and protects against diseases such as diabetes, neurodegenerative disorders, and autoimmune conditions. Comprising bacteria, viruses, fungi, and other microorganisms, this vast ecosystem is essential but often overlooked in its impact on health. It transforms dietary components into important neurotransmitters and antioxidants, including serotonin and indole-3-propionic acid (IPA). However, factors like poor diet, excessive hygiene, stress, and antibiotic use can disrupt this delicate balance by decreasing microbial diversity and impairing function. The gut microbiota is linked not only to digestive diseases but also to mental health conditions. This chapter emphasises the influence of stress, probiotics, circadian rhythms, diet, and environmental exposures on the gut microbiota’s interaction with brain function via the gut-brain axis—a bidirectional communication system. It explores how gut microbes affect the nervous system through neurotransmitters, the endocrine system, immune mechanisms, and microbial metabolites. Additionally, it discusses how alterations in gut microbiota may be involved in psychiatric disorders such as major depressive disorder (MDD), schizophrenia (SCZ), bipolar disorder (BD), autism spectrum disorder (ASD), and attention-deficit hyperactivity disorder (ADHD).

 

 

Author(s) Details

Chandrasekar R
Department of Pharmacognosy, Faculty of Pharmacy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Pooja R.P
Department of Pharmacognosy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Sadhana A
Department of Pharmacognosy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Snehalatha K
Department of Pharmacognosy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Prasanna Venkatesh J
Department of Pharmacognosy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Selvakumar M
Department of Pharmacognosy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Sivagami B

Department of Pharmaceutical Analysis, Faculty of Pharmacy, Seven Hills College of Pharmacy, Tirupati, AP, India.

 

Kumanan R
Department of Pharmacognosy, Faculty of Pharmacy, Devaki Amma Memorial College of Pharmacy, Malappuram, 673634, Kerala, India.

 

Please see the book here :- https://doi.org/10.9734/bpi/psnid/v9/6889

Tuesday, 28 October 2025

Gut Microbiota as a Modulator of Insulin Resistance: A Review | Chapter 7 | Medical Science: Recent Advances and Applications Vol. 12

 

Insulin resistance is the pivotal pathogenic component of many metabolic diseases, including type 2 diabetes mellitus, and is defined as a state of reduced responsiveness of insulin-targeting tissues to physiological levels of insulin. Recent studies have progressively uncovered aspects of the gut microbiota and how it contributes to the metabolism of key nutrients during IR. The purpose of this review is to examine the role of gut microbiota as a modulator of insulin resistance. Growing evidence indicates that dysbiosis, marked by reduced microbial diversity and an imbalance between beneficial and harmful species, contributes to metabolic dysfunction. Key findings show that a higher Firmicutes-to-Bacteroidetes ratio, the inflammatory action of lipopolysaccharide (LPS), and the beneficial effects of short-chain fatty acids (SCFAs) are central to understanding the link between microbiota and host metabolism. Protective taxa such as Akkermansia muciniphila and Faecalibacterium prausnitzii support metabolic stability, while endotoxin elevation worsens inflammation and insulin resistance. Current therapeutic strategies—including diet modification, physical activity, prebiotics, probiotics, and faecal microbiota transplantation (FMT)—demonstrate potential in restoring microbial balance. Despite these advances, challenges such as interindividual variability and the need for standardised, long-term trials remain. In conclusion, gut microbiota should be regarded not as a passive indicator but as an active therapeutic modulator with strong potential in the prevention and management of insulin resistance.

 


Author(s) Details

Noor Ali Hussein
Babylon Education Directorate, Ministry of Education, Hillah, Iraq.

 

Please see the book here :- https://doi.org/10.9734/bpi/msraa/v12/6442

Thursday, 6 February 2025

The Main Genome is a Natural Mechanism for Fighting Infections and Somatic Diseases | Chapter 5 | Achievements and Challenges of Medicine and Medical Science Vol. 10

All infectious diseases of viral and bacterial nature, as well as somatic diseases such as diabetes mellitus, cardiovascular pathology, oncology, autoimmune diseases, mental disorders, nervous diseases, etc., appear as a result of the process of adaptation of the organism during the transfer of genetic material from the main genome to a macroorganism – plants and animals. The main genome in the evolutionary or adaptive process of all living things on the planet is the genome of bacteria (prokaryotes, including archaea). The adaptation of bacteria themselves to a changing environment has been going on continuously at the genetic level since the appearance of life on the planet. Further, these changes from bacteria are transmitted to multicellular organisms for their improvement (adaptation to a new environment). To do this, bacteria use retrovirus-like mechanisms (in one place, a part of the genome is cut out from bacteria, in another place, in particular, into the human genome, this part is inserted). As one of these mechanisms, bacteria have a system of spacer adaptation: the CRISPR/Cas system. In this case, the bacterial genome adapted to the new environment is transferred to the macroorganism to adapt its immune and hormonal systems to new conditions. So, normally, the natural mechanism of adaptation or improvement of animals and plants is carried out, i.e. the mechanism of countering the occurrence of infections and somatic diseases. Careful use of the mechanism given by nature will allow for solving the problems of diagnosis, prevention and therapy of many infectious and somatic diseases.

 

Author (s) Details

 

A.S. Vladyko
Republican Scientific and Practical Center of Epidemiology and Microbiology of the Ministry of Health of the Republic of Belarus, Minsk, Belarus.

 

A. S. Petkevich
Republican Scientific and Practical Center of Epidemiology and Microbiology of the Ministry of Health of the Republic of Belarus, Minsk, Belarus.

 

Please see the book here:- https://doi.org/10.9734/bpi/acmms/v10/3604

 

Monday, 4 September 2023

Efficacy of Various Root Canal Irrigants in Primary Teeth - An Overview | Chapter 7 | Current Progress in Medicine and Medical Research Vol. 8

This branch highlights about the efficacy of various Root canal irrigants in Primary dentition. The preservation of integrity of basic dentition is ultimate important aspect of deterrent dentistry, and it is vital to maintain the primary dentition just before its sane exfoliation, as it is essential for the normal tumor of facial-wasted complex. The microbiota in the root canal is a complicated squash-up of bacterial species. When compared to the microbiota unique from clinically symptomatic dentition, the microbiota recovered from asymptomatic teeth is specific. It is concluded that Irrigating answers are essential to the success of endodontic situation of primary dentition because the likelihood of a favorable outcome accompanying root canal therapy is significantly increased if contamination is adequately eliminated before the root waterway system is obturated.

Author(s) Details:

Jaya Agali Ramachandra,
Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka, India.

Please see the link here: https://stm.bookpi.org/CPMMR-V8/article/view/11738

Thursday, 28 July 2022

Nutrigenomics and Microbiomics, Contrasting Interpretations of Dismetabolic Diseases | Chapter 11 | Research Aspects in Biological Science Vol. 4

 

In this paper, we examined current interpretations based on Nutrigenomica and Microbiomic research, according to which, at the root of many pathological and dismetabolic manifestations, there'd be or variations of single nucleotide polymorphisms (Snps) in the Nutrigenomic perspective, or modifications in the normal gut microbiota in the Microbiomic perspective.We have examined rigorously the singular pathogenic coincidence, which raises questions about Snps mutations or the presence of specific Microbiota changes for the same illnesses.

As a result, other possible causes of detected disorders are overlooked.
We will give an alternative understanding of pathogenic causes based on the research reviewed.

Author(s) Details:

Bruno Riccardi,
Representative Lipotech, 56022 Castelfranco di Sotto (PI), Via dei Lazzeri, 33, Italy.

Sergio Resta,
Freelancer, 53043 Chiusi (SI), Via Montegrappa 1, Italy.

Giacomo Resta,
Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Perugia, Italy.

Please see the link here: https://stm.bookpi.org/RABS-V4/article/view/7594

Monday, 18 October 2021

A Review on Xenobiotics: The Impact of SARS-CoV-2 on the Evolutionary Development of Human | Chapter 06 | Issues and Development in Health Research Vol. 6

This is a topic that will be discussed in the analytical section of this article, where South Africans' priorities for HIV/AIDS and health will be compared. This study examines the characteristics that predicted respondents' selection of HIV/AIDS as an important issue for the government to solve using data from the Fourth Round of the Afrobarometer survey in South Africa. The study's dependent variable was the identification of HIV/AIDS as a significant governmental issue. Other possibly key factors included respondents' personal knowledge of HIV/AIDS, such as knowing someone who died of AIDS, poverty, and their perceptions of the government's response to the HIV/AIDS issue. A logistic regression analysis took into account the respondent's background and demographic information. The findings revealed three characteristics that influenced respondent choice of HIV/AIDS: race, particularly being a Black South African, government prioritisation of health, and the rural-urban divide. The conclusion was that advertising aimed at mobilising public support for comprehensive HIV/AIDS solutions in South Africa should focus on HIV/AIDS rather than health.

Author(S) Details

A. Vladyko
Republican Scientific and Practical Center for Epidemiology and Microbiology, Minsk, Belarus.

E. Fomina
Republican Scientific and Practical Center for Epidemiology and Microbiology, Minsk, Belarus.

P. Semizhon
Republican Scientific and Practical Center for Epidemiology and Microbiology, Minsk, Belarus.

View Book:- https://stm.bookpi.org/IDHR-V6/article/view/4246

Thursday, 12 August 2021

New Interpretations of Nutrigenomics and Microbiomics | Chapter 3 | Recent Progress in Microbiology and Biotechnology Vol. 7

 In this paper, we examine current interpretations based on Nutrigenomica and Microbiomics studies, according to which, at the root of many pathological and dismetabolic manifestations, there would be or variations of single nucleotide polymorphisms (Snps) in the Nutrigenomic perspective, or changes in the normal gut microbiota in the Microbiomic perspective.


We examine critically the single pathogenic coincidence, which raises questions about Snps mutations or the presence of specific Microbiota changes for the same illnesses.

As a result, other plausible causes of detected disorders are overlooked.

We propose a distinct understanding of pathogenic aetiology based on the literature reviewed. Nutrigenomic study focuses solely on variations in genetic polymorphisms, while Microbiomic research focuses solely on changes in the intestinal microbiome, with the goal of determining their implications on health.

Author (S) Details

Bruno Riccardi
Castelfranco di Sotto (PI), Via dei Lazzeri, Italy.

Sergio Resta
Department of Surgery, General Surgery Specialist, Freelancer, 53043 Chiusi (SI), Via Montegrappa, Italy.

Roberto Fabbroni

Roberto Fabbroni, Scientific Director of I.B.I. ( Istituto di Biofisica Informazionale), Italy.

View Book :- https://stm.bookpi.org/RPMB-V7/article/view/2573

Thursday, 15 July 2021

Study on Defensive Mechanism of Respiratory System | Chapter 10 | Highlights on Medicine and Medical Science Vol. 7

 The purpose of this article is to outline the various components that make up the respiratory system's defence systems. Mechanical barrier phenomena, humoral substances, and cells from both the innate and particular adaptive immune responses are all part of the respiratory system's defence. The barrier mechanisms and the innate immune response are the first line of lung protection. Dendritic cells (DC) interact with infections and antigens by transmitting information to lymph nodes in the lungs, which results in an adaptive immune response. DCs connect the innate and adaptive immune responses in this way. The adaptive immune response is targeted by antibodies and particular T cells that work together in a synergistic and coordinated manner. Furthermore, immunological memory is formed. The ability to control immune response by improving protection mechanisms (e.g. vaccinations, immunostimulants) or lowering allergy, autoimmune, or chronic inflammatory illnesses of the respiratory system has been made possible by understanding these pathways (eg. corticosteroids, biologics).


Author (S) Details

Arnoldo Quezada
Department of Pediatrics, School of Medicine, University of Chile, Santiago, Chile.

View Book :- https://stm.bookpi.org/HMMS-V7/article/view/2038